Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuharu Ueda

Showing results (91-100 of 381) with videos related to

Pageof 39
Sort By:
Clinical Therapeutics|August 18, 2020
Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing SurveillanceTomonori Ishii, Yoko Hirano, Noriko Matsumoto, et al.
Geriatrics (Basel, Switzerland)|December 24, 2025
Analysis of Clinical Characteristics and Rehabilitation Outcomes in Elderly Patients with Parkinson's Disease: A Retrospective StudyToshiya Shimamoto, Yohei Misumi, Katsuhisa Uchino, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 22, 2017
Tongue strength in patients with subacute myelo-optico-neuropathySatoshi Yamashita, Tatsuya Nakama, Mitsuharu Ueda, et al.
Neurology|July 25, 2024
Rapidly Progressive Gait Disturbance and Extensive Iron Deposits in Late-Onset MPAN With a Pathogenic <i>C19orf12</i> Variant: An 8-Year Follow-upMayuko Imura, Keiichi Nakahara, Kentaro Hara, et al.
Annals of Clinical Biochemistry|January 10, 2018
Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatmentTokunori Ikeda, Teruaki Masuda, Mitsuharu Ueda, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 12, 2022
Binding of serum-derived amyloid-associated proteins to amyloid fibrilsYohei Misumi, Yuri Tabata, Masayoshi Tasaki, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 24, 2014
Myopathic phenotype of familial amyloid polyneuropathy with a rare transthyretin variant: ATTR Ala45AspYohei Misumi, Tsukasa Doki, Mitsuharu Ueda, et al.
International Journal of Molecular Sciences|August 26, 2022
SIRT7 Deficiency Protects against Aβ<sub>42</sub>-Induced Apoptosis through the Regulation of NOX4-Derived Reactive Oxygen Species Production in SH-SY5Y CellsHironori Mizutani, Yoshifumi Sato, Masaya Yamazaki, et al.
Cureus|March 17, 2025
A Case of Nebulin-Related Nemaline Myopathy With Asymmetric Distal Lower Limb WeaknessHironori Mizutani, Yohei Misumi, Kohei Hamanaka, et al.
Journal of Human Genetics|April 8, 2024
Long-term course of a case with a novel homozygous kyphoscoliosis peptidase variantYohei Misumi, Taro Yamashita, Aki Kuratomi, et al.
Pageof 39

Showing results (91-100 of 381) with videos related to

Sort By:
Pageof 39
Clinical Therapeutics|August 18, 2020
Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing SurveillanceTomonori Ishii, Yoko Hirano, Noriko Matsumoto, et al.
Geriatrics (Basel, Switzerland)|December 24, 2025
Analysis of Clinical Characteristics and Rehabilitation Outcomes in Elderly Patients with Parkinson's Disease: A Retrospective StudyToshiya Shimamoto, Yohei Misumi, Katsuhisa Uchino, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 22, 2017
Tongue strength in patients with subacute myelo-optico-neuropathySatoshi Yamashita, Tatsuya Nakama, Mitsuharu Ueda, et al.
Neurology|July 25, 2024
Rapidly Progressive Gait Disturbance and Extensive Iron Deposits in Late-Onset MPAN With a Pathogenic <i>C19orf12</i> Variant: An 8-Year Follow-upMayuko Imura, Keiichi Nakahara, Kentaro Hara, et al.
Annals of Clinical Biochemistry|January 10, 2018
Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatmentTokunori Ikeda, Teruaki Masuda, Mitsuharu Ueda, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 12, 2022
Binding of serum-derived amyloid-associated proteins to amyloid fibrilsYohei Misumi, Yuri Tabata, Masayoshi Tasaki, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 24, 2014
Myopathic phenotype of familial amyloid polyneuropathy with a rare transthyretin variant: ATTR Ala45AspYohei Misumi, Tsukasa Doki, Mitsuharu Ueda, et al.
International Journal of Molecular Sciences|August 26, 2022
SIRT7 Deficiency Protects against Aβ<sub>42</sub>-Induced Apoptosis through the Regulation of NOX4-Derived Reactive Oxygen Species Production in SH-SY5Y CellsHironori Mizutani, Yoshifumi Sato, Masaya Yamazaki, et al.
Cureus|March 17, 2025
A Case of Nebulin-Related Nemaline Myopathy With Asymmetric Distal Lower Limb WeaknessHironori Mizutani, Yohei Misumi, Kohei Hamanaka, et al.
Journal of Human Genetics|April 8, 2024
Long-term course of a case with a novel homozygous kyphoscoliosis peptidase variantYohei Misumi, Taro Yamashita, Aki Kuratomi, et al.
Pageof 39